Skip to main content
    G

    GlucoTrack Inc (GCTK)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $0.19
    -0.03 (-14.35%)

    Market Cap: $2.43M

    Last updated: Nov 16, 2026 at 4:00 PM ET

    GlucoTrack Inc (GCTK) Statistics

    Updated Nov 16, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    GlucoTrack (GCTK) has a market cap of $2.43M and an enterprise value of $3.24M. Its share count is up 912.95% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 33.62% above the market cap, as debt exceeds cash.

    Market Cap$2.43M
    Enterprise Value$3.24M
    Close (Nov 16, 2026)$0.19

    Key Dates

    Last Earnings DateAug 14, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 205.78% in the quarter ended Jun 30, 2026.

    Shares Outstanding166.97K
    Shares Change (YoY)+912.95%
    Shares Change (QoQ)+205.78%

    Price Statistics

    The stock is down 99.89% over 52 weeks and trades 92.24% below its 50-day average.

    Beta (1Y)3.47
    52-Week Change-99.89%
    1-Month Change-86.87%
    3-Month Change-98.16%
    6-Month Change-98.69%
    5-Year Change-100.00%
    10-Year Change-100.00%
    Total Return (1Y)-99.89%
    Total Return (3Y CAGR)-98.10%
    Total Return (5Y CAGR)-95.05%
    Max Drawdown (1Y)-99.91%
    Max Drawdown (3Y)-100.00%
    Sharpe Ratio (1Y)-3.11
    Correlation with SPY (1Y)0.22
    50-Day Average$2.45
    200-Day Average$17.78
    52-Week Range$0.75 to $207.00
    RSI (14 Days)27.7
    Average Volume (20 Days)3.68M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.46x current liabilities.

    Current Ratio0.46x
    Quick Ratio0.46x

    Returns and Efficiency

    Return on invested capital is -6319.21% over the last 12 months.

    Return on Assets (ROA)-1066.69%
    Return on Invested Capital (ROIC)-6319.21%

    Scores

    GCTK has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$14.00K
    Operating Income-$15.40M
    Pretax Income-$15.95M
    Net Income-$15.95M
    EBITDA-$15.38M
    EBIT-$15.92M

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$1.12M
    Total Debt$1.94M
    Net Debt$816.00K
    Net Debt Per Share$4.89
    Working Capital-$1.61M
    Shareholder Equity-$1.74M
    Total Assets$1.50M
    Total Liabilities$3.24M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$16.22M
    FCF Per Share-$16.02
    Depreciation and Amortization$541.00K

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Dividends and Yields

    GCTK does not pay a dividend.

    Buyback Yield-11132.08%
    Shareholder Yield-11132.08%

    Stock Splits

    The last split was a 1-for-2 reverse split on Oct 26, 2026.

    Last Split DateOct 26, 2026
    Split TypeReverse split
    Split Ratio1:2

    Peer Position

    Against 6 similar companies, GCTK has the lowest ROIC.

    ROIC-6319.21% vs -130.26% median
    Revenue Growth (Trailing 4 Quarters, YoY)-100.00% vs +41.62% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About GCTK

    What is GCTK's market cap?

    GlucoTrack has a market cap of $2.43M. Its enterprise value, which adds debt and subtracts cash, is $3.24M.

    How many shares of GCTK are outstanding?

    GlucoTrack has 166.97K shares outstanding. The count is up 912.95% from a year earlier.

    Does GCTK pay a dividend?

    No. GlucoTrack does not pay a dividend.

    How much debt does GCTK have?

    GlucoTrack has $1.94M of total debt and $1.12M of cash and equivalents, a net debt position of $816.00K.